When will Medroxyprogesterone Acetate Tablet be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Medroxyprogesterone Acetate Tablet changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Medroxyprogesterone Acetate Tablet

Brand names: Provera

Category: Urology

Not specified 2

FDA status: To Be Discontinued · Last FDA update: Aug 31, 2026 · First posted: Aug 31, 2026 · 1 manufacturers, 2 listed presentations

As of Aug 31, 2026, the FDA lists Medroxyprogesterone Acetate Tablet as being discontinued. Of 2 manufacturer presentations, 2 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Medroxyprogesterone Acetate Tablet is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01) NDC 0009-0065-01	Pfizer Inc.	Not specified	Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.
PROVERA, Tablet, 10 mg (NDC 0009-0051-01) NDC 0009-0051-01	Pfizer Inc.	Not specified	Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026.

Related medications in shortage

Other Urology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Medroxyprogesterone Acetate Tablet (FDA data as of Aug 31, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Medroxyprogesterone Acetate Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Medroxyprogesterone Acetate Tablet.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/medroxyprogesterone-acetate-tablet.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).